A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test.
Deep brain stimulation of the subthalamic nucleus is an effective treatment option for Parkinson's disease. In our lab we established a protocol to screen different neurostimulation patterns in hemiparkinsonian (unilateral lesioned) rats. It consists of creating a unilateral Parkinson's lesion by injecting 6-hydroxydopamine (6-OHDA) into the right medial forebrain bundle, implanting chronic stimulation electrodes into the subthalamic nucleus and evaluating motor outcomes at the end of 24 hr periods of cable-bound external neurostimulation. The stimulation was conducted with constant current stimulation. The amplitude was set 20% below the individual threshold for side effects. The motor outcome evaluation was done by the assessment of spontaneous paw use in the cylinder test according to Shallert and by the assessment of skilled reaching in the staircase test according to Montoya. This protocol describes in detail the training in the staircase box, the cylinder test, as well as the use of both in hemiparkinsonian rats. The use of both tests is necessary, because the staircase test seems to be more sensitive for fine motor skill impairment and exhibits greater sensitivity to change during neurostimulation. The combination of the unilateral Parkinson model and the two behavioral tests allows the assessment of different stimulation parameters in a standardized way.
Department of Neurology, University Hospital Wuerzburg; mig.zuk@vp.pl.
Marta
M
Rattka
Department of Neurology, University Hospital Wuerzburg.
Felix
F
Fluri
Department of Neurology, University Hospital Wuerzburg.
Miloš
M
Krstić
Institute of Anatomy and Cell Biology, University Wuerzburg.
Esther
E
Asan
Department of Neurology, University Hospital Wuerzburg; volkmann_j@ukw.de.
Jens
J
Volkmann
D000818:Animals; D046690:Deep Brain Stimulation; D008474:Medial Forebrain Bundle / Q000187:drug effects / Q000473:pathology; D016627:Oxidopamine / Q000633:toxicity; D010300:Parkinson Disease / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D051381:Rats; D020531:Subthalamic Nucleus
D016627:Oxidopamine